Abstract:Abstract: Objectives To compare the spinal anesthesia efficiency of Ropivacaine, Bupivacaine, and Lidocaine using for patients undergoing knee arthroscopy. Methods 99 patients were included in this prospective, double-blinded, randomize controlled trial and randomly allocated to receive either 25.0 mg Ropivacaine, 15.0 mg Bupivacaine or 40.0 mg Lidocaine. The primary endpoint was the time until complete recovery of sensory block. Secondary endpoints included time to recovery from motor block, failure rates, incidence of hypotension/bradycardia, postoperative pain, first mobilization, voiding and discharge times, and the incidence of transient neurologic symptoms. Results Patients in the Ropivacaine group had a significantly shorter time until recovery from sensory block (2.6 ± 1.2) than patients in the Lidocaine group (3.1 ± 1.7; P = 0.006) and in the Bupivacaine group (6.1 ± 2.5; P = 0.000). Ropivacaine was associated with a significantly faster recovery from motor block than Lidocaine and Bupivacaine. Times to first mobilization, voiding, and discharge were significantly shorter for Ropivacaine when compared with Bupivacaine, but not with Lidocaine. In the Bupivacaine group, patients need less rescue medication for postoperative pain when compared with Lidocaine and Ropivacaine. Groups did not differ with respect to patient satisfaction, incidence of bradycardia/hypotension, and transient neurologic symptom rate. Conclusions For spinal anesthesia in patients undergoing ambulatory knee arthroscopy, Ropivacaine has the shortest time to complete recovery of sensory and motor block compared with Bupivacaine and Lidocaine.